Alterations of c-Myc and c-erbB-2 Genes in Ovarian Tumours

被引:2
作者
Pastor, Tibor [1 ]
Popovic, Branka [1 ]
Gvozdenovic, Ana [1 ]
Boro, Aleksandar [1 ]
Petrovic, Bojana [2 ]
Novakovic, Ivana [3 ]
Puzovic, Dragana [1 ]
Lukovic, Ljiljana [3 ]
Milasin, Jelena [1 ]
机构
[1] Univ Belgrade, Sch Dent, Inst Forens Med, Belgrade, Serbia
[2] Clin Ctr Serbia, Inst Gynecol & Obstet, Belgrade, Serbia
[3] Univ Belgrade, Sch Med, Inst Human Genet, Belgrade, Serbia
关键词
c-Myc oncogene amplification; c-erbB-2 oncogene amplification; dPCR; ovarian tumours; CANCER; AMPLIFICATION; CARCINOMA; ONCOGENE; GROWTH; BREAST; STAGE;
D O I
10.2298/SARH0902047P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction According to clinical and epidemiological studies, ovarian cancer ranks fifth in cancer deaths among women. The causes of ovarian cancer remain largely unknown but various factors may increase the risk of developing it, such as age, family history of cancer, childbearing status etc. This cancer results from a succession of genetic alterations involving oncogenes and tumour suppressor genes, which have a critical role in normal cell growth regulation. Mutations and/or overexpression of three oncogenes, c-erbB-2, c-Myc and K-ras, and of the tumour suppressor gene p53, have been frequently observed in a sporadic ovarian cancer. Objective The aim of the present study was to analyse c-Myc and c-erbB-2 oncogene alterations, specifically amplification, as one of main mechanisms of their activation in ovarian cancers and to establish a possible association with the pathogenic process. Methods DNA was isolated from 15 samples of malignant and 5 benign ovarian tumours, using proteinase K digestion, followed by phenol-chloroform isoamyl extraction and ethanol precipitation. C-Myc and c-erbB-2 amplification were detected by differential PCR. The level of gene copy increase was measured using the Scion image software. Results The amplification of both c-Myc and c-erbB-2 was detected in 26.7% of ovarian epithelial carcinoma specimens. Only one tumour specimen concomitantly showed increased gene copy number for both studied genes. Interestingly, besides amplification, gene deletion was also detected (26.7% for c-erbB-2). Most of the ovarian carcinomas with alterations in c-Myc and c-erbB-2 belonged to advanced FIGO stages. Conclusion The amplification of c-Myc and c-erbB-2 oncogenes in ovarian epithelial carcinomas is most probably a late event in the pathogenesis conferring these tumours a more aggressive biological behaviour. Similarly, gene deletions point to genomic instability in epithelial carcinomas in higher clinical stages as the result of clonal evolution and selection.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 19 条
  • [1] HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma
    Afify, AM
    Werness, BA
    Mark, HFL
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1999, 66 (02) : 163 - 169
  • [2] C-MYC AMPLIFICATION IN OVARIAN-CANCER
    BAKER, VV
    BORST, MP
    DIXON, D
    HATCH, KD
    SHINGLETON, HM
    MILLER, D
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 38 (03) : 340 - 342
  • [3] Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer
    Chen, CH
    Shen, J
    Lee, WJ
    Chow, SN
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (05) : 878 - 883
  • [4] COMEY CT, 1994, J FORENSIC SCI, V39, P1254
  • [5] Dang CV, 1999, MOL CELL BIOL, V19, P1
  • [6] Gardner L., 2002, ENCY CANC, P1
  • [7] GRAMLICH TL, 1994, AM J CLIN PATHOL, V101, P493
  • [8] AMPLIFICATION OF A NOVEL V-ERBB-RELATED GENE IN A HUMAN MAMMARY-CARCINOMA
    KING, CR
    KRAUS, MH
    AARONSON, SA
    [J]. SCIENCE, 1985, 229 (4717) : 974 - 976
  • [9] ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma
    Lassus, H
    Leminen, A
    Vayrynen, A
    Cheng, GJ
    Gustafsson, JÅ
    Isola, J
    Butzow, R
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 31 - 39
  • [10] Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer:: correlation to clinicopathological variables
    Launonen, V
    Mannermaa, A
    Stenbäck, F
    Kosma, VM
    Puistola, U
    Huusko, P
    Anttila, M
    Bloigu, R
    Saarikoski, S
    Kauppila, A
    Winqvist, R
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 122 (01) : 49 - 54